Trial Profile
Ranibizumab in Haemorrhagic Choroidal Neovascularisation Trial
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Choroidal neovascularisation; Wet age-related macular degeneration
- Focus Therapeutic Use
- 15 Aug 2014 New trial record
- 02 Oct 2009
- 05 May 2008